Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.00
Bid: 12.50
Ask: 13.50
Change: 0.00 (0.00%)
Spread: 1.00 (8.00%)
Open: 13.00
High: 0.00
Low: 0.00
Prev. Close: 13.00
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wipac Strategy Update

11 Jun 2019 07:00

RNS Number : 7458B
Carclo plc
11 June 2019
 

11 June 2019

 

Carclo plc ("Carclo" or the "Group")

 

Wipac Strategy Update

 

Carclo plc ("Carclo" or the "Group"), a global manufacturer of fine tolerance injection moulded plastic parts mainly for the medical, automotive lighting and optics markets, issues this strategy update ahead of the Group announcing its results, for the year-ended 31 March 2019, on 23 July.

 

Overall, Group performance in the first weeks of the current financial year, and Group net debt levels, have been broadly as anticipated. The Technical Plastics and Aerospace Divisions performed strongly but operating losses at Wipac, the main operating business in the Group's LED Technologies Division, have increased, with the business continuing to incur additional costs to meet growing customer demand.

 

In light of the ongoing challenges, and in order to establish a more sustainable platform for Wipac, the Board is reviewing the strategy for the business, in particular the move into the mid-volume vehicle market, which is placing significant strain on the Group. As part of this review, Wipac is working with its customers to develop a plan to refocus the operation on its historic low-volume vehicle markets where it had previously been financially successful. This plan might involve customers moving some programmes to alternative suppliers. Once implemented, the revised strategy is likely to have the effect of reducing Wipac's future sales revenue but would also, consequently, significantly reduce the Group's cash requirements for working capital and capital expenditure. The Board expects to be able to provide more detailed guidance on the financial implications of the revised strategy at the time of the full-year results announcement.

 

In the meantime, and as previously announced, discussions remain on going with the bank and other stakeholders in relation to the refinancing of the Group's borrowing facilities due to mature in March 2020. An interim Chief Restructuring Officer has been appointed to assist with these discussions.

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

Enquiries:

Carclo plc

01924 268040

Mark Rollins - Executive Chairman

Sarah Matthews De-Mers - Finance Director

FTI Consulting

020 3727 1340

Nick Hasell / Susanne Yule

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDURUKRKOANAAR
Date   Source Headline
26th Feb 20197:00 amRNSHolding(s) in Company
22nd Feb 201910:52 amRNSHolding(s) in Company
19th Feb 20199:39 amRNSAppointment of Chief Operating Officer
19th Feb 20199:16 amRNSHolding(s) in Company
7th Feb 20193:32 pmRNSHolding(s) in Company
6th Feb 20195:57 pmRNSHolding(s) in Company
6th Feb 20191:57 pmRNSHolding(s) in Company
6th Feb 20191:56 pmRNSHolding(s) in Company
6th Feb 201911:51 amRNSHolding(s) in Company
6th Feb 201911:51 amRNSDirector/PDMR Shareholding
31st Jan 201911:12 amRNSHolding(s) in Company
16th Jan 201912:37 pmRNSHolding(s) in Company
16th Jan 201911:43 amRNSHolding(s) in Company
11th Jan 20197:00 amRNSTrading Statement
21st Nov 20182:49 pmRNSHolding(s) in Company
13th Nov 20187:00 amRNSHalf-year Report
12th Oct 20187:00 amRNSTrading Update
29th Aug 20185:08 pmRNSHolding(s) in Company
13th Aug 201811:39 amRNSDirector/PDMR Shareholding
9th Aug 20188:08 amRNSForm 8.3 - [Carclo plc]
9th Aug 20187:24 amRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Aug 20187:20 amRNSForm 8.5 (EPT/RI) - Carclo Plc
8th Aug 20188:46 amRNSForm 8.3 - [Carclo plc]
7th Aug 20181:46 pmRNSHolding(s) in Company
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
7th Aug 201810:36 amRNSForm 8.3 - [Carclo plc]
7th Aug 20189:43 amRNSStatement re withdrawal of Consort Medical plc
7th Aug 20188:23 amRNSConsort Medical No Intention to Bid for Carclo plc
3rd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
3rd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
2nd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
2nd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
1st Aug 20182:52 pmRNSDirector/PDMR Shareholding
1st Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
1st Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
1st Aug 20189:47 amRNSForm 8 (DD) - Carclo
1st Aug 20189:41 amRNSForm 8 (DD) - Carclo
1st Aug 20189:38 amRNSPerformance Share Plan
1st Aug 20188:19 amRNSForm 8.3 - [Carclo plc]
31st Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
31st Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
31st Jul 201811:01 amRNSForm 8 (DD) - Carclo
31st Jul 201810:54 amRNSDirector/PDMR Shareholding
31st Jul 20189:27 amRNSForm 8.3 - [Carclo plc]
30th Jul 20181:49 pmRNSForm 8.3 - [Carclo plc]
30th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
30th Jul 201811:48 amRNSForm 8 (DD) - Carclo
27th Jul 20182:38 pmRNSForm 8.3 - [Carclo plc]
27th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.